Recent reports suggest that lycopene can suppress the proliferation of prostate cancer cells through the activation of peroxisome proliferator-activated receptor γ (PPARγ), liver X receptor α (LXRα), and ATP-binding cassette transporter ABCA1 (180). Here, ABCA1 is linked to prostate carcinoma.